NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference
04:09 EDT 13 Aug 2012 | PR Newswire
This article has expired, however you can still
download the PDF.
Preview:
LAWRENCE, Mass., Aug. 10, 2012 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced that Jeffrey H. Burbank, Chief Executive Officer, will present at the Canaccord Genuity 32nd A...
Other Sources for this Article
More From BioPortfolio on "NxStage to Present at the Canaccord Genuity 32nd Annual Growth Conference"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
